MedPath

Effectiveness of Vitamin E as an add on with standard therapy and its effect on patients with chronic kidney disease on renal dialysis

Phase 3
Completed
Conditions
Health Condition 1: N185- Chronic kidney disease, stage 5
Registration Number
CTRI/2021/08/036020
Lead Sponsor
SRM Institute of Scince and Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
152
Inclusion Criteria

Patients of either gender, suffering from chronic kidney disease on hemodialysis at least for 3 months and age of 40 years to 70 years.

CKD patients on haemodialysis who were able to understand and agree for informed written informed consent for the participation in this study.

CKD patients on haemodialysis with Diabetes mellitus and hypertension as co-morbidities.

Exclusion Criteria

CKD patients on haemodialysis who were disable or immobile.

CKD patients on haemodialysis with associated chronic liver disease (CLD), congestive heart failure (CHF), HIV, Active tuberculosis.

CKD patients on haemodialysis with immunosuppressive therapy and clinical signs of ongoing infection.

CKD patients with haemodialysis not on antioxidant therapy for last 3-6 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath